P
PASG
Passage Bio, Inc.
8.80
+0.72+8.91%Opening14:29 04/06 EDT
OPEN/PREV CLOSE8.75/8.22
TODAY RANGE8.06-8.75
VOL31.00K
MARKET CAP26.69M
52 WEEK RANGE5.12-20.00
AVG VOL (3M)46.36K
% TURNOVER0.97%
TURNOVER--
P/E (TTM)-0.5799
% RANGE8.46%
EPS(TTM)-14.3473
P/E(FORWARD)-1.1335
P/B1.412
BVPS5.89
DIVIDEND--
P/S--
BETA--
DIV YIELD0.00%
FREE FLOAT MKT CAP26.56M
SHARES OUTSTANDING3.21M
NEXT EARNINGS05/11-05/15
FREE FLOAT3.19M
LOT SIZE1
EX-DATE07/14/2025
News
Press Releases
Financial Reports
Profile
Benzinga·04/01 12:05
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Dow Jones·03/31 14:07
Passage Bio Price Target Announced at $30.00/Share by Oppenheimer
Dow Jones·03/31 14:07
Passage Bio Initiated at Outperform by Oppenheimer
Reuters·03/31 07:39
U.S. RESEARCH ROUNDUP-Dutch Bros, Phreesia, Starbucks
TipRanks·03/30 20:14
Passage Bio initiated with an Outperform at Oppenheimer
Benzinga·03/19 12:06
12 Health Care Stocks Moving In Thursday's Pre-Market Session
TipRanks·03/10 11:55
Passage Bio Ends Hopewell Lab Lease, Extends Cash Runway
Dow Jones·03/04 19:11
Passage Bio Price Target Cut to $23.00/Share From $67.00 by Canaccord Genuity
Dow Jones·03/04 19:11
Passage Bio Is Maintained at Buy by Canaccord Genuity
Benzinga·03/04 19:01
Canaccord Genuity Maintains Buy on Passage Bio, Lowers Price Target to $23
TipRanks·03/04 12:21
Passage Bio price target lowered to $23 from $67 at Canaccord
Same Industry
Name/Symbol
Change%
Price